TCBWMS
AZN icon

Texas Capital Bank Wealth Management Services’s AstraZeneca AZN Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Sell
1,705
-3
-0.2% -$578 0.02% 259
2025
Q4 		$314K Buy
+1,708
New +$300K 0.02% 252
2024
Q3 		– Sell
-1,575
Closed -$246K – 207
2024
Q2 		$246K Hold
1,575
– – 0.03% 170
2024
Q1 		$213K Buy
+1,575
New +$209K 0.02% 178

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Texas Capital Bank Wealth Management Services's AZN Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services reduced its AstraZeneca (AZN) stake by 0.18% in Q1 2026, selling an estimated $578 and leaving 1,705 shares worth $330K. The position accounts for 0.02% of the portfolio, ranked #259.

Texas Capital Bank Wealth Management Services first reported a position in AZN in Q1 2024 and has held it in 4 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 1,705 shares of AstraZeneca worth $330K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services sold 3 AstraZeneca shares in Q1 2026, an estimated $578.
  • AstraZeneca made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #259 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in AstraZeneca in Q1 2024 and has held it in 4 quarters since.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.